Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial

Florian von Groote-Bidlingmaier, Ramonde Patientia, Epifanio Sanchez, Vincent Balanag, Eduardo Ticona, Patricia Segura, Elizabeth Cadena, Charles Yu, Andra Cirule, Victor Lizarbe, Edita Davidaviciene, Liliana Domente, Ebrahim Variava, Janice Caoili, Manfrid Danilovits, Virgaine Bielskiene, Suzanne Staples, Norbert Hittel, Carolyn Petersen, Charles WellsJeffrey Hafkin, Lawrence J. Geiter, Rajesh Gupta

Resultado de la investigación: Contribución a una revistaArtículorevisión exhaustiva

81 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial'. En conjunto forman una huella única.

Medicina y ciencias biológicas